American Invest Hub
  • Politics
  • Investing
  • Business
  • Latest News

American Invest Hub

  • Politics
  • Investing
  • Business
  • Latest News
Investing

Colgate-Palmolive stock analysis: overvalued ahead of earnings

by admin January 30, 2025
January 30, 2025
Colgate-Palmolive stock analysis: overvalued ahead of earnings

The Colgate-Palmolive stock price remains in a deep correction as investors wait for the fourth-quarter results. CL has plunged by over 17%, bringing its market cap to about $73 billion. So, is Colgate a good stock to buy the dip in?

Colgate-Palmolive is a good value company

Colgate-Palmolive is a leading company in the consumer staples industry. The firm operates its business in two key segments: oral, personal, and home care, and pet nutrition. It is one of the biggest players in the industry, owning brands like Colgate, Sorriso, Tom’s of Maine, and Sanex. 

Colgate-Palmolive’s business has done well in the past few years as its annual revenue rose from $15.7 billion in 2019 to over $20 billion in the trailing twelve months (TTM). The net income has moved from $2.16 billion in 2021 to over $2.86 billion.

The next key catalyst for the Colgate-Palmolive stock will be its upcoming financial results, which will come out on Friday. Analysts anticipate that the company’s revenue will come in at $5 billion, a 0.78% increase from the same period a year ago.

Colgate-Palmolive’s annual revenue will come in at $20.15 billion, a 3.52% annual increase. Its 2025 revenue guidance will be $20.39 billion, a 1.27% annual increase. 

These numbers mean that Colgate’s growth has largely stalled and is underperforming other companies. As such, it has become highly overvalued, with a forward P/E ratio of 25.45, up from the sector median of 18.5. The trailing-twelve-month P/E ratio of 25.8 is also higher than the sector median of 21. 

Still, analysts are optimistic that its stock wil rebound in the future. The Colgate stock forecast is $100, up from the current $89.57. The most notable bullish analysts are RBC Capital, Stifel, and UBS. 

Read more: Colgate-Palmolive (CL): dividend king stock gets overbought

Colgate-Palmolive stock price analysis

CL stock price chart by TradingView

The weekly chart shows that the CL share price peaked at $108.25 in 2024 and has now dropped to $85.80, its lowest point in April last year. 

It has stalled at the 38.2% Fibonacci Retracement point. It has moved between the 50-week and 100-week moving averages. It is hovering at the strong pivot reverse point of the Murrey Math Lines tool.

Therefore, the Colgate-Palmolive stock price will likely drop after earnings. If this happens, the next point to watch will be the 50% retracement level at $78.20 or 12% below the current level. This is an important level since it was also the highest point in 2020, 2021, 2022, and 2023. This view will be confirmed if drops below the support at $85.80. 

On the flip side, a move above the 23.60% retracement point at $94.40 will invalidate the bearish view.

The post Colgate-Palmolive stock analysis: overvalued ahead of earnings appeared first on Invezz

0
FacebookTwitterGoogle +Pinterest
previous post
IBM stock price analysis: risky pattern points to a retreat in 2025
next post
CVS Health stock price is recovering: Feb 12 will be crucial

Related Posts

Here’s why the Ocado share price may surge...

April 25, 2025

GBP/USD forecast ahead of US NFP data as...

September 4, 2025

USD/HUF, USD/SEK, USD/CZK analysis ahead of rate decisions

September 24, 2024

EHang stock: What next for this Joby and...

March 13, 2025

Coniagas Battery Metals to Participate in THE Mining...

May 31, 2024

Best crypto to buy as the fear and...

May 16, 2025

XRP price prediction: 3 reasons Ripple is about...

August 11, 2025

Pi Network price analysis: a risky pattern emerges

April 14, 2025

Here’s why the Iron ore and copper prices...

January 14, 2025

Here’s why Hyperliquid’s HYPE price is in a...

June 16, 2025

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Latest News

    • Senate Democrats scale back demands in bid to end historic US government shutdown

      November 9, 2025
    • US government shutdown: Republicans reject Democrats’ pared-back offer

      November 9, 2025
    • Weekly wrap: Mamdani win, SC questions Trump’s tariffs, Tesla approves Musk pay package

      November 9, 2025
    • Market outlook: uncertainty looms as data blackout tests investor nerves

      November 9, 2025
    • Bulgaria plans for continuous oil supply for Lukoil-owned refinery after US sanctions

      October 26, 2025

    Categories

    • Business (4,555)
    • Investing (3,077)
    • Latest News (2,107)
    • Politics (1,541)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: americaninvesthub.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 americaninvesthub.com | All Rights Reserved